BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 25228802)

  • 21. Folate decorated magnetite nanoparticles: synthesis and targeted therapy against ovarian cancer.
    Fazilati M
    Cell Biol Int; 2014 Feb; 38(2):154-63. PubMed ID: 23956031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pH-sensitive doxorubicin prodrug based on folate-conjugated BSA for tumor-targeted drug delivery.
    Du C; Deng D; Shan L; Wan S; Cao J; Tian J; Achilefu S; Gu Y
    Biomaterials; 2013 Apr; 34(12):3087-97. PubMed ID: 23374705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GSH and enzyme responsive nanospheres based on self-assembly of green tea polyphenols and BSA used for target cancer chemotherapy.
    Zhang J; Ren X; Tian X; Zhang P; Chen Z; Hu X; Mei X
    Colloids Surf B Biointerfaces; 2019 Jan; 173():654-661. PubMed ID: 30368213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, in silico modelling and functionality theory of folate-receptor-targeted myricetin-loaded bovine serum albumin nanoparticle formulation for cancer treatment.
    Kunjiappan S; Govindaraj S; Parasuraman P; Sankaranarayanan M; Arunachalam S; Palanisamy P; Mohan UP; Babkiewicz E; Maszczyk P; Vellaisamy S; Panneerselvam T
    Nanotechnology; 2020 Apr; 31(15):155102. PubMed ID: 31775133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro evaluation of a Folate-bovine serum albumin-doxorubicin conjugate.
    Qu X; Yang C; Zhang J; Ding N; Lu Y; Huang L; Xiang G
    J Drug Target; 2010 Jun; 18(5):351-61. PubMed ID: 20001219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced tumor delivery and antitumor response of doxorubicin-loaded albumin nanoparticles formulated based on a Schiff base.
    Li F; Zheng C; Xin J; Chen F; Ling H; Sun L; Webster TJ; Ming X; Liu J
    Int J Nanomedicine; 2016; 11():3875-90. PubMed ID: 27574421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thermal and pH responsive polymer-tethered multifunctional magnetic nanoparticles for targeted delivery of anticancer drug.
    Sahoo B; Devi KS; Banerjee R; Maiti TK; Pramanik P; Dhara D
    ACS Appl Mater Interfaces; 2013 May; 5(9):3884-93. PubMed ID: 23551195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Folate-bovine serum albumin functionalized polymeric micelles loaded with superparamagnetic iron oxide nanoparticles for tumor targeting and magnetic resonance imaging.
    Li H; Yan K; Shang Y; Shrestha L; Liao R; Liu F; Li P; Xu H; Xu Z; Chu PK
    Acta Biomater; 2015 Mar; 15():117-26. PubMed ID: 25595473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Folate-conjugated boron nitride nanospheres for targeted delivery of anticancer drugs.
    Feng S; Zhang H; Yan T; Huang D; Zhi C; Nakanishi H; Gao XD
    Int J Nanomedicine; 2016; 11():4573-4582. PubMed ID: 27695318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted delivery of Doxorubicin by folic acid-decorated dual functional nanocarrier.
    Lu J; Zhao W; Huang Y; Liu H; Marquez R; Gibbs RB; Li J; Venkataramanan R; Xu L; Li S; Li S
    Mol Pharm; 2014 Nov; 11(11):4164-78. PubMed ID: 25265550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Folic acid decorated metal-organic frameworks loaded with doxorubicin for tumor-targeted chemotherapy of osteosarcoma.
    Xu W; Lou Y; Chen W; Kang Y
    Biomed Tech (Berl); 2020 Apr; 65(2):229-236. PubMed ID: 31605575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. pH-Triggered Surface Charge Reversed Nanoparticle with Active Targeting To Enhance the Antitumor Activity of Doxorubicin.
    Du JB; Cheng Y; Teng ZH; Huan ML; Liu M; Cui H; Zhang BL; Zhou SY
    Mol Pharm; 2016 May; 13(5):1711-22. PubMed ID: 26998644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of tumor-targeted folate conjugated fluorescent magnetic albumin nanoparticles for enhanced intracellular dual-modal imaging into human brain tumor cells.
    Wang X; Tu M; Tian B; Yi Y; Wei Z; Wei F
    Anal Biochem; 2016 Nov; 512():8-17. PubMed ID: 27523645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of magnetic folate-dextran-retinoic acid micelles for dual targeting of doxorubicin in breast cancer.
    Varshosaz J; Sadeghi-aliabadi H; Ghasemi S; Behdadfar B
    Biomed Res Int; 2013; 2013():680712. PubMed ID: 24381941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimization of the preparation process of vinblastine sulfate (VBLS)-loaded folate-conjugated bovine serum albumin (BSA) nanoparticles for tumor-targeted drug delivery using response surface methodology (RSM).
    Zu Y; Zhang Y; Zhao X; Zhang Q; Liu Y; Jiang R
    Int J Nanomedicine; 2009; 4():321-33. PubMed ID: 20054435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mesoporous γ-Iron Oxide Nanoparticles for Magnetically Triggered Release of Doxorubicin and Hyperthermia Treatment.
    Benyettou F; Ocadiz Flores JA; Ravaux F; Rezgui R; Jouiad M; Nehme SI; Parsapur RK; Olsen JC; Selvam P; Trabolsi A
    Chemistry; 2016 Nov; 22(47):17020-17028. PubMed ID: 27739116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation of DOX/BSANP and its antitumor effect on bel-7404 liver cancer cells in vitro and in vivo.
    Miao FQ; An YL; Yang R; Tang QS; Zhang JQ
    Biomed Mater Eng; 2014; 24(1):599-607. PubMed ID: 24211944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Theranostic, pH-Responsive, Doxorubicin-Loaded Nanoparticles Inducing Active Targeting and Apoptosis for Advanced Gastric Cancer.
    Ma H; Liu Y; Shi M; Shao X; Zhong W; Liao W; Xing MM
    Biomacromolecules; 2015 Dec; 16(12):4022-31. PubMed ID: 26477267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Folate-modified doxorubicin-loaded nanoparticles for tumor-targeted therapy.
    Wu G; Wang Z; Bian X; Du X; Wei C
    Pharm Biol; 2014 Aug; 52(8):978-82. PubMed ID: 25017652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnetic albumin immuno-nanospheres as an efficient gene delivery system for a potential use in lung cancer: preparation, in vitro targeting and biological effect analysis.
    Hou X; Zhang H; Li H; Zhang D
    J Drug Target; 2016; 24(3):247-56. PubMed ID: 26325231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.